Clinical Trial

Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This single-arm, non-randomized, open-label investigation aims to collect safety and efficacy data of the CE-Marked Netrod™ RDN System in treating European patients with primary hypertension in the absence of anti-hypertensive medication.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-02; most recent amendment 2026-02-09.
Trial Details
NCT Number NCT07061054
Lead Sponsor Shanghai Golden Leaf MedTec Co. Ltd
Collaborators: North American Science Associates Ltd.
Conditions Uncontrolled Hypertension
Enrollment 20 participants
Start Date 2026-04-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-11